This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

OptumRx asks US judge to compel arbitration of pharmacies' US antitrust claims

( April 25, 2025, 20:50 GMT | Official Statement) -- MLex Summary: OptumRx told a US judge that a proposed plaintiff class of pharmacies' US antitrust claims alleging an unlawful tying arrangement should not proceed in court because the pharmacies had contracts with OptumRx requiring individual arbitration of "any and all" disputes between the parties. The contracts are explicit that class actions are not permitted, which the plaintiffs have ignored, OptumRx's motion to compel individual arbitration filed in the Western District of Washington said. "Plaintiffs accepted significant compensation for years from OptumRx under their contracts... and now rely on the contracts' terms to seek additional reimbursements in this lawsuit," it said.See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections